StockData
CVR Partners, LP logo

CVR Partners, LP (UAN) stock analysis

UANNYSEAgricultural ChemicalsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 15/3054% below fair value
$112.92+0.47 (+0.42%)

Close on Nov 11, 2026Market cap $1.19BP/E 7.4Yield –

StockData Score

Prices as of Nov 11, 2026How the score works

Value6Growth2Performance2Health2Dividend3

Solid15 of 30 checks passed

CVR Partners, LP passes 15 of the 30 checks behind our score; 13 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
6/6
Growth
2/6
Past performance
2/6
Financial health
2/6
Dividend
3/6

What stands out

  • Margin of safety over 20%

    The price is 53.9% below fair value, more than the 20% cushion we look for.

  • Trading below fair value

    The share price of $112.92 is below our fair value estimate of $244.74.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 37.2% of total debt.

  • P/E below its 5-year median

    CVR Partners, LP's P/E of 7.4 is below its own 5-year median of 8.6.

What to watch

  • Revenue growing under 10% a year

    Revenue grew -10.2% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing under 10% a year

    Diluted EPS grew -29.9% a year over the last three fiscal years.

Valuation6/6
  • P/E below its 5-year median

    CVR Partners, LP's P/E of 7.4 is below its own 5-year median of 8.6.

  • P/E below the industry

    CVR Partners, LP's P/E of 7.4 is below the Chemicals and Allied Products median of 25.2.

  • EV/EBITDA below its 5-year median

    CVR Partners, LP's EV/EBITDA of 5.9 is below its 5-year median of 6.6.

  • P/S below the industry

    CVR Partners, LP's price-to-sales of 1.76 is below the Chemicals and Allied Products median of 3.35 (book value is negative, so we use sales).

  • Trading below fair value

    The share price of $112.92 is below our fair value estimate of $244.74.

  • Margin of safety over 20%

    The price is 53.9% below fair value, more than the 20% cushion we look for.

Growth2/6
  • Revenue growing under 10% a year

    Revenue grew -10.2% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing under 10% a year

    Diluted EPS grew -29.9% a year over the last three fiscal years.

  • Earnings acceleration

    Needs positive net income now, a year ago and five years ago.

  • Growing faster than the industry

    Revenue grew 17.5% over the last twelve months; the Chemicals and Allied Products median is 3.5%.

  • Guidance issued

    The latest outlook (Q4 2026 Direct operating expenses, Nov 3, 2026) was issued for the first time, so it neither adds nor takes away points.

  • Gross margin improving

    Gross margin was 33.5% over the last twelve months, against 25.8% a year earlier.

Past performance2/6
  • Return on equity

    Needs positive equity and five years of results.

  • Return on invested capital

    Needs operating income and invested capital.

  • Return on equity against the industry

    Needs positive equity.

  • Earnings over 5 years

    Needs positive net income five years ago and in the latest year.

  • Net margin above its 5-year average

    Net margin was 23.7% over the last twelve months, against a 5-year average of 20.4%.

  • Net margin above the industry

    CVR Partners, LP's net margin of 23.7% is above the Chemicals and Allied Products median of -9.4%.

Financial health2/6
  • Debt level

    Needs debt and equity figures.

  • Debt trend

    Needs a balance sheet from five years ago with positive equity.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 37.2% of total debt.

  • Interest coverage

    Interest expense is not reported separately.

  • Short-term assets cover short-term debts

    Current assets are 3.01 times current liabilities.

  • Bankruptcy risk (Altman Z)

    Needs market value, working capital and retained earnings.

Dividend3/6
  • Pays a dividend

    CVR Partners, LP paid dividends worth 9.3% of the share price over the last twelve months.

  • Yield above Treasuries

    The 9.3% yield is above the 4.4% on a 1-year Treasury.

  • Yield in the top quarter

    The top quarter of US dividend payers yield 3.8% or more; CVR Partners, LP yields 9.3%.

  • Dividend stability

    Fewer than five years of dividend history.

  • Earnings cover

    Needs dividends paid and net income.

  • Cash-flow cover

    Needs dividends paid and free cash flow.

Scores of similar companies

Our estimate per share

$244.74

The share price is 54% below this estimate.

20%+ below
Near fair value
20%+ above
$112.92Price$244.74Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E16.8×8.6×25.2×$255.0844%
EV/EBITDA11.5×6.6×16.6×$259.4939%
Earnings power7.4% cost of equity––$182.7617%
Fair value$244.74100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 8.6
  • Chemicals and Allied Products median 25.2

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Medium risk

Average value traded per day
$3.27M
Value traded per 1% price move
$2.82M

Downside

Low risk

Typical loss in a bad month
13.6%
Volatility (annualized)
42%
Sharpe ratio, 1 year
0.28
Beta to the S&P 500 (5Y)
0.51

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Gross margin

27.0%+19.9 pts over 5 years

Operating margin

21.2%+31.2 pts over 5 years

Net margin

16.3%+44.3 pts over 5 years

See a number that looks wrong?